Page 127 - 《中国药房》2024年24期
P. 127

1例军团菌重症肺炎抗感染治疗药学监护及文献分析                                                          Δ



                                          2 #
          李 芳 ,王 宁 ,金 典 ,龙秀英 ,曾尚霞 ,魏京霞(1.成都市第六人民医院药剂科,成都 610051;2.成都
                                                            1
                                                   2
                          2
                                  1
                 1*
          市第六人民医院神经内科,成都 610051)
          中图分类号  R969.3      文献标志码  A      文章编号  1001-0408(2024)24-3081-06
          DOI  10.6039/j.issn.1001-0408.2024.24.20
          摘  要  目的  为军团菌重症肺炎抗感染治疗药学监护提供治疗思路与参考。方法  临床药师参与1例军团菌重症肺炎患者治疗
          全过程,协助临床医师根据患者临床症状、体征、肺部影像学变化等,利用WUH(Winthrop-University Hospital criteria)评分系统评
          估感染病原体,利用其药学专业知识,建议哌拉西林钠他唑巴坦钠联合盐酸莫西沙星抗感染,实时监护患者的临床表现;及时发现
          患者谵妄和脂肪酶、淀粉酶、肝酶异常升高,分析原因后,先后建议调整治疗方案为哌拉西林钠他唑巴坦钠联合多西环素或阿奇霉
          素抗感染,并配合保肝治疗、肠内营养、肠外营养。此外,临床药师还密切关注患者的用药依从性并对其进行用药教育。结果  临
          床医师采纳临床药师的建议,患者治疗后好转出院,1个月后复查无反复。结论  临床药师在协助临床医师治疗军团菌重症肺炎
          时,不仅需关注患者临床症状、体征的改变,还需密切监测氟喹诺酮类、四环素类以及大环内酯类抗菌药物的不良反应,及时识别
          不良反应并提供治疗方案调整建议,并为患者提供全程药学监护,保证临床治疗的有效性和安全性。
          关键词  重症肺炎;军团菌;药学监护;不良反应;临床药师;WUH评分系统


          Anti-infective  treatment  for  a  severe  case  of  Legionella  pneumonia:  pharmaceutical  care  and  literature
          analysis
          LI Fang ,WANG Ning ,JIN Dian ,LONG Xiuying ,ZENG Shangxia ,WEI Jingxia(1.  Dept.  of  Pharmacy,
                                                                         2
                                                                                      1
                              2
                 1
                                         1
                                                        2
          Chengdu  Sixth  People’s  Hospital,  Chengdu  610051,  China;2.  Dept.  of  Neurology,  Chengdu  Sixth  People’s
          Hospital, Chengdu 610051, China)
          ABSTRACT   OBJECTIVE  To  provide  certain  therapeutic  ideas  and  references  for  the  pharmaceutical  care  of  severe  Legionella
          pneumonia in anti-infection treatment. METHODS Clinical pharmacists participated in the entire treatment process of a patient with
          severe  Legionella  pneumonia,  and  assisted  clinical  physicians  in  evaluating  the  infecting  pathogens  using  the  WUH (Winthrop-
          University  Hospital  criteria)  scoring  system,  based  on  the  patient’s  clinical  symptoms,  physical  signs,  and  changes  in  pulmonary
          imaging.  Leveraging  their  pharmaceutical  expertise,  clinical  pharmacists  recommended  a  combination  of  piperacillin  sodium  and
          tazobactam with moxifloxacin hydrochloride for anti-infection treatment, and closely monitored the patient’s clinical manifestations.
          They promptly identified delirium and abnormally elevated levels of lipase, amylase and liver enzymes, and successively suggested
          adjusting  the  treatment  plan  to  a  combination  of  piperacillin  sodium  and  tazobactam  with  doxycycline  or  azithromycin  for  anti-
          infection  after  analyzing  the  causes,  along  with  liver  protection  treatment,  enteral  nutrition,  and  parenteral  nutrition. Additionally,
          clinical pharmacists closely monitor the patient’s medication adherence and provide her with medication education. RESULTS The
          clinical  physicians  accepted  the  recommendations  of  the  clinical  pharmacists,  and  the  patient  improved  after  treatment  and  was
          discharged. A follow-up examination one month later showed no recurrence. CONCLUSIONS Clinical pharmacists, when assisting
          clinicians  in  treating  severe  Legionella  pneumonia,  not  only  pay  attention  to  changes  in  the  patient’s  clinical  symptoms  and
          physical  signs,  but  also  closely  monitor  the  adverse  reactions  of  fluoroquinolone,  tetracycline,  and  macrolide  antibiotics.  They
          should  promptly  recognize  adverse  reactions  and  provide  recommendations  for  adjusting  treatment  plans,  as  well  as  offer
          comprehensive pharmaceutical care throughout the patient’s treatment, to ensure the effectiveness and safety of clinical therapy.
          KEYWORDS    severe pneumonia; Legionella; pharmaceutical care; adverse reactions; clinical pharmacist; WUH scoring system



             Δ 基金项目 成都市医学科研课题立项项目(No.2023641)                    军团菌肺炎是由军团菌引起的细菌性肺炎,属于传
             *第一作者 主管药师,硕士。研究方向:临床药学。E-mail:                 染性疾病,是一种较为严重的社区获得性肺炎和院内感
          catherine_lf@126.com
                                                             染。军团菌是一类需氧革兰氏阴性杆菌,是造成临床军
             # 通信作者 主任医师。研究方向:脑血管病的防治。E-mail:
          464480368@qq.com                                   团菌肺炎的主要病原体,广泛存在于温暖、潮湿的环境


          中国药房  2024年第35卷第24期                                              China Pharmacy  2024 Vol. 35  No. 24    · 3081 ·
   122   123   124   125   126   127   128   129   130   131   132